Allergan Funding SCS

CIK 1620554 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Allergan Funding SCS.

Recent SEC filings

FiledFormAccession number
May 21, 202015-15D0001193125-20-148772
May 21, 202015-15D0001193125-20-148779
May 21, 202015-15D0001193125-20-148782
May 21, 202015-12B0001193125-20-148768
May 18, 2020EFFECT9999999995-20-001181
May 14, 2020POS AM0001193125-20-142884
May 14, 2020POSASR0001193125-20-142875
May 11, 2020250001193125-20-138336
Jun 3, 201925-NSE0000876661-19-000525
Nov 16, 2018CERT0000876661-18-001225
Nov 15, 20188-A12B0001193125-18-328024
Nov 9, 2018424B20001193125-18-323916
Nov 8, 2018424B50001193125-18-321737
Nov 8, 2018FWP0001193125-18-322711
Feb 16, 2018S-3ASR0001193125-18-048741
May 26, 20178-A12B0001193125-17-185741
May 25, 2017424B20001193125-17-183813
May 25, 201725-NSE0000876661-17-000278
May 23, 2017424B50001193125-17-178683
May 23, 2017FWP0001193125-17-179796
May 10, 2017FWP0001193125-17-165105
Mar 18, 2015CERTNYS9999999997-15-005306
Mar 17, 20158-A12B0001193125-15-095387
Mar 5, 2015424B20001193125-15-078819
Mar 3, 2015FWP0001193125-15-075312